Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-4-27
pubmed:abstractText
Mathematical simulation models for transmission and control of lymphatic filariasis are useful tools for studying the prospects of lymphatic filariasis elimination. Two simulation models are currently being used. The first, EPIFIL, is a population-based, deterministic model that simulates average trends in infection intensity over time. The second, LYMFASIM, is an individual-based, stochastic model that simulates acquisition and loss of infection for each individual in the simulated population, taking account of individual characteristics. For settings like Pondicherry (India), where Wuchereria bancrofti infection is transmitted by Culex quinquefasciatus, the models give similar predictions of the coverage and number of treatment rounds required to bring microfilaraemia prevalence below a level of 0.5%. Nevertheless, published estimates of the duration of mass treatment required for elimination differed, due to the use of different indicators for elimination (EPIFIL: microfilaraemia prevalence < 0.5% after the last treatment; LYMFASIM: reduction of microfilaraemia prevalence to zero, within 40 years after the start of mass treatment). The two main challenges for future modelling work are: 1) quantification and validation of the models for other regions, for investigation of elimination prospects in situations with other vector-parasite combinations and endemicity levels than in Pondicherry; 2) application of the models to address a range of programmatic issues related to the monitoring and evaluation of ongoing control programmes. The models' usefulness could be enhanced by several extensions; inclusion of different diagnostic tests and natural history of disease in the models is of particular relevance.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-10581617, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-10858649, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-10982078, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-11169273, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-11299035, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-12510894, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-12613767, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-12625928, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-12630391, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-1441569, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-14593597, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-1470476, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-1475823, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15050941, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15180315, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15267110, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15463584, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15552405, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15664532, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15964428, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-15964448, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-16033148, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-16038391, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-16282298, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-2255837, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-2311368, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-3904343, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-8009211, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-8761566, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-8940971, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-9550218, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-9550853, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-9633111, http://linkedlifedata.com/resource/pubmed/commentcorrection/16569234-9790439
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:issn
1475-2883
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5
pubmed:dateRevised
2009-11-18
pubmed:year
2006
pubmed:articleTitle
Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.
pubmed:affiliation
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P,O, Box 2040, 3000 CA Rotterdam, The Netherlands. w.stolk@erasmusmc.nl
pubmed:publicationType
Journal Article